Search company, investor...
AntriaBio company logo

The profile is currenly unclaimed by the seller. All information is provided by CB Insights.


Reverse Merger | IPO

Total Raised


About AntriaBio

AntriaBio offers the diabetes product candidate, AB101, a once-a-week injectable basal insulin that is currently in preclinical development. AB101 is administered by subcutaneous injection and targets patients with type 1 and type 2 diabetes who require basal insulin for the control of hyperglycemia.In February 2013, Fits My Style merged with AntriaBio. Due to the merger, AntriaBio is now listed and trading on the OTC Bulletin Board and the OTCQB under the symbol "FMYY."

AntriaBio Headquarters Location

890 Santa Cruz Ave

Menlo Park, California, 94025,

United States


Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing AntriaBio

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

AntriaBio is included in 2 Expert Collections, including Diabetes.



1,750 items


Biopharma Tech

5,241 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.

AntriaBio Patents

AntriaBio has filed 8 patents.

The 3 most popular patent topics include:

  • Aerodynamics
  • Colloidal chemistry
  • Dosage forms
patents chart

Application Date

Grant Date


Related Topics




Fluid dynamics, Dosage forms, Colloidal chemistry, Drug delivery devices, Aerodynamics


Application Date


Grant Date



Related Topics

Fluid dynamics, Dosage forms, Colloidal chemistry, Drug delivery devices, Aerodynamics



Latest AntriaBio News

Louisville-based bioscience firm Rezolute lays off half of staff

Apr 12, 2018

LOUISVILLE – Rezolute Inc., the bioscience company based in Louisville and formerly known as AntriaBio Inc., has laid off about half of its roughly 50-employee staff and has eliminated its manufacturing operation. The Daily Camera reports that the layoffs came less than a week after Rezolute  announced it had raised $5 million  on a round of convertible note financing to be used for working capital as well as the appointment of Hoyoung Huh as company vice chairman. It’s unclear whether the financing and board appointment are related to the layoffs.

  • Where is AntriaBio's headquarters?

    AntriaBio's headquarters is located at 890 Santa Cruz Ave, Menlo Park.

  • What is AntriaBio's latest funding round?

    AntriaBio's latest funding round is Reverse Merger.

  • How much did AntriaBio raise?

    AntriaBio raised a total of $2.64M.

  • Who are the investors of AntriaBio?

    Investors of AntriaBio include Fits My Style.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.